MannKind Corp
MNKD
#5703
Rank
โ‚ฌ1.19 B
Marketcap
3,73ย โ‚ฌ
Share price
7.05%
Change (1 day)
-20.51%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2023 (TTM): -0,18ย โ‚ฌ

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -0,12ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,30ย โ‚ฌ a decrease over its 2021 EPS that were of -0,29ย โ‚ฌ.

EPS history for MannKind Corp from 2004 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,18ย โ‚ฌ-40.14%
2022-0,30ย โ‚ฌ6.25%
2021-0,29ย โ‚ฌ28%
2020-0,22ย โ‚ฌ-7.41%
2019-0,24ย โ‚ฌ-55.74%
2018-0,54ย โ‚ฌ-45.05%
2017-0,99ย โ‚ฌ-188.1%
20161,13ย โ‚ฌ-128.31%
2015-3,97ย โ‚ฌ74.51%
2014-2,28ย โ‚ฌ-20.31%
2013-2,86ย โ‚ฌ-32.63%
2012-4,24ย โ‚ฌ-28.03%
2011-5,89ย โ‚ฌ-12%
2010-6,70ย โ‚ฌ-27.54%
2009-9,24ย โ‚ฌ-30.3%
2008-13,26ย โ‚ฌ-18.85%
2007-16,34ย โ‚ฌ-19.03%
2006-20,18ย โ‚ฌ56.94%
2005-12,86ย โ‚ฌ-21.74%
2004-16,43ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,68ย โ‚ฌ-684.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
3,64ย โ‚ฌ-3,236.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
27,56ย โ‚ฌ-23,843.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,89ย โ‚ฌ-863.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
3,14ย โ‚ฌ-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-2,64ย โ‚ฌ 2,176.92%๐Ÿ‡บ๐Ÿ‡ธ USA